February 2019 Briefing – Hematology & Oncology

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — The proportion of human papillomavirus (HPV) 16/18-positive cervical intraepithelial neoplasia grades 2 to 3 or adenocarcinoma in situ (CIN2+) declined from 2008 to […]

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — The proportion of human papillomavirus (HPV) 16/18-positive cervical intraepithelial neoplasia grades 2 to 3 or adenocarcinoma in situ (CIN2+) declined from 2008 to 2014, according to a study published online Feb. 21 in Cancer Epidemiology, Biomarkers & Prevention.

Abstract/Full Text (subscription or payment may be required)

Tumor Control Durable With Pembrolizumab in Merkel Cell Cancer

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — For patients with advanced Merkel cell carcinoma (aMCC), pembrolizumab is associated with durable tumor control and favorable overall survival, according to a study published online Feb. 7 in the Journal of Clinical Oncology.

Abstract/Full Text (subscription or payment may be required)

Poor Food Intake Common in Hospitalized Patients

MONDAY, Feb. 25, 2019 (HealthDay News) — Approximately one-third of adult inpatients are at risk for malnutrition and poorer outcomes due to not eating their meals, despite being allowed to eat, according to a study recently published in the Journal of Parenteral and Enteral Nutrition.

Abstract/Full Text (subscription or payment may be required)

Stereotactic Radiation Feasible for Oligometastatic Cancer

TUESDAY, Feb. 26, 2019 (HealthDay News) — Stereotactic ablative radiation therapy (SABR) for recurrent oligometastatic cancer is a feasible and tolerable treatment option, according to a phase 2 study published in the January issue of the International Journal of Radiation Oncology, Biology, Physics.

Abstract/Full Text

Single-Application FIT Moderately Sensitive, Specific for CRC

MONDAY, Feb. 25, 2019 (HealthDay News) — Single-application fecal immunochemical tests (FITs) have moderate-to-high sensitivity and specificity for colorectal cancer (CRC), according to a review published online Feb. 26 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

FDA: Thermography No Substitute for Mammograms

MONDAY, Feb. 25, 2019 (HealthDay News) — Despite claims to the contrary, thermography should not be used in place of mammography for breast cancer screening, detection, or diagnosis, according to the U.S. Food and Drug Administration.

More Information

Genetic Variant Tied to Leukemia Risk in Hispanic Children

MONDAY, Feb. 25, 2019 (HealthDay News) — Genetic variations have been identified in the ERG gene that are associated with an increased risk for acute lymphoblastic leukemia (ALL) in Hispanic children, according to a study recently published in Blood.

Abstract/Full Text (subscription or payment may be required)

2014 to 2017 Saw Improvement in Burnout for U.S. Physicians

MONDAY, Feb. 25, 2019 (HealthDay News) — From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.

Abstract/Full Text

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
Page 2 of 10
« Prev | Next »